SCHEMBL7723384

SCHEMBL7723384

COc1ccccc1-c1nc2nc(SC)nnc2c(=O)[nH]1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALPL P05186 1/20 0.51
FGFR1 P11362 3/20 0.51
FGFR2 P21802 3/20 0.51
PDE5A O76074 4/20 0.46
AURKA O14965 1/20 0.46
ALDH1A1 P00352 2/20 0.45
MAPT P10636 2/20 0.45
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
KDM4E B2RXH2 1/20 0.45
PDE2A O00408 1/20 0.45
PDE6D O43924 1/20 0.45
USP2 O75604 1/20 0.45
PDE9A O76083 1/20 0.45
LMNA P02545 1/20 0.45
CYP1A2 P05177 1/20 0.45
HPGD P15428 1/20 0.45
ALOX15 P16050 1/20 0.45
PDE6A P16499 1/20 0.45
PDE6G P18545 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7721820 0.85 PDE5A (0.65) PDE5AALDH1A1MAPTMEN1KMT2A
SCHEMBL7723452 0.85 PDE5A (0.53) PDE5AALDH1A1MAPTMEN1KMT2A
SCHEMBL7726085 0.84 PDE5A (0.47) PDE5AALDH1A1MAPTMEN1KMT2A
SCHEMBL7725949 0.83 PDE5A (0.53) PDE5AALDH1A1MAPTMEN1KMT2A
SCHEMBL7718573 0.80 MEN1 (0.67) ALPLFGFR1FGFR2PDE5AAURKA
SCHEMBL7718072 0.77 PDE5A (0.65) PDE5AALDH1A1MAPTMEN1KMT2A
SCHEMBL7721531 0.73 PDE5A (0.69) PDE5AALDH1A1MAPTMEN1KMT2A
SCHEMBL7721526 0.69 PDE5A (0.67) PDE5AALDH1A1MAPTMEN1KMT2A
SCHEMBL7726863 0.69 MEN1 (0.64) PDE5AALDH1A1MAPTMEN1KMT2A
SCHEMBL1084872 0.69 GUSB (0.78) KDM4ECYP1A2HPGDGUSBPARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0347146-B1 FUSED PYRIMIDINE DERIVATIVES, PROCESS AND INTERMEDIATES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1993-09-01 EP claimed
EP-0347146-A2 Fused pyrimidine derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1989-12-20 EP claimed
US-6391885-B1 CONTROLLING APOPTOSIS IN AUTOIMMUNE DISEASE CELL PATHWAYS, INC. 2002-05-21 US disclosed
US-6060477-A Method of treating a patient having precancerous lesions with phenyl cycloamino pyrimidinone derivatives CELL PATHWAYS, INC. (US) 2000-05-09 US disclosed
EP-0347146-B1 FUSED PYRIMIDINE DERIVATIVES, PROCESS AND INTERMEDIATES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1993-09-01 EP disclosed
US-5047404-A Fused pyrimidine derivatives bronchodilator agents, antiallergens SMITH KLINE & FRENCH LABORATORIES, LTD. (GB) 1991-09-10 US disclosed
EP-0347146-A2 Fused pyrimidine derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1989-12-20 EP disclosed